Advanced Biomed Inc.
For the period ended Jun 30, 2026. Filed Oct 13, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Oct 13, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
Following the disposition of our Taiwan subsidiary on June 30, 2026, our operations and research and development activities are based in Hong Kong. Our principal executive office is located at Units No. 12, 12th Floor, Tower 1, W MEGA, No. 251 Texaco Road and No. 28 Wang Lung Street, Tsuen Wan, New Territories, Hong Kong. Our Hong Kong premises support our day-to-day operations and the research and development of FinTruth.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.